ABC News Many patients who contracted mpox during the 2022 outbreak experienced physical effects more than a year later, a new study published on Monday finds.
Researchers from the Centers for Disease Control and Prevention (CDC), Columbia University’s division of Infectious siseases and the University of Texas Health Science Center looked at more than 300 adults who were either diagnosed with mpox between May 2022 and January 2023 or were at risk but never infected.
They found that more than half — 58% — of those who were diagnosed with mpox during the 2022 outbreak still had lingering physical effects between 11 and 18 months later, according to the study, published in the journal Annals of Internal Medicine.
